Clinical and pathophysiological characteristics of acute-onset functional dyspepsia

Background & Aims: Functional bowel disorders may follow acute intestinal infection. In animals, postinflammatory dysmotility is associated with nitrergic dysfunction. The aim of this study was to identify and characterize patients with presumed postinfectious dyspepsia (PD) compared with unspec...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Gastroenterology (New York, N.Y. 1943) N.Y. 1943), 2002-06, Vol.122 (7), p.1738-1747
Hauptverfasser: Tack, Jan, Demedts, Ingrid, Dehondt, Geert, Caenepeel, Philip, Fischler, Benjamin, Zandecki, Michele, Janssens, Jozef
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1747
container_issue 7
container_start_page 1738
container_title Gastroenterology (New York, N.Y. 1943)
container_volume 122
creator Tack, Jan
Demedts, Ingrid
Dehondt, Geert
Caenepeel, Philip
Fischler, Benjamin
Zandecki, Michele
Janssens, Jozef
description Background & Aims: Functional bowel disorders may follow acute intestinal infection. In animals, postinflammatory dysmotility is associated with nitrergic dysfunction. The aim of this study was to identify and characterize patients with presumed postinfectious dyspepsia (PD) compared with unspecified-onset dyspepsia (UD). Methods: A total of 400 consecutive dyspeptic patients filled out a questionnaire to assess whether their symptoms were of postinfectious origin. They underwent testing for Helicobacter pylori infection as well as gastric emptying and gastric barostat studies. Pharmacological studies of nitrergic gastric function were performed in controls, in patients with presumed PD, and in patients with UD using sumatriptan, an activator of nitrergic neurons, and amylnitrite, a nitric oxide donor. Results: Presumed PD was present in 17% of the patients and associated with more prevalent early satiety, weight loss, nausea, and vomiting compared with UD. Both groups did not differ in H. pylori infection, gastric emptying, or gastric sensitivity. Impaired accommodation was significantly more prevalent in patients with presumed PD (67% vs. 30%; P < 0.05). Sumatriptan relaxed the stomach in controls and patients with UD but not in patients with presumed PD, whereas amyl nitrite relaxed the stomach in all subjects. Conclusions: A subset of dyspeptic patients has a history suggestive of postinfectious dyspepsia. These patients have a high prevalence of impaired accommodation attributable to a dysfunction at the level of gastric nitrergic neurons. GASTROENTEROLOGY 2002;122:1738-1747
doi_str_mv 10.1053/gast.2002.33663
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71797288</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0016508502000069</els_id><sourcerecordid>71797288</sourcerecordid><originalsourceid>FETCH-LOGICAL-c354t-d72a88836736b4214036710b0770fe97cefc60d5b20d98988be99f5bb163b1d83</originalsourceid><addsrcrecordid>eNp10M-P1CAUwHFiNO64evZmetFbZx8wFDiaib-STTyoZ0LhdQfTKZVHTea_t7MzyZ48PUI-vJAvY285bDkoeffgqW4FgNhK2XXyGdtwJUwLwMVztllH1yow6oa9IvoNAFYa_pLdcAFKKW037Md-TFMKfmz8FJvZ10OeDydKecwPj9fh4IsPFUuimgI1eWh8WCq2eSKszbBMoaY8rTKeaMaZkn_NXgx-JHxznbfs1-dPP_df2_vvX77tP963QapdbaMW3hgjOy27fif4DtYjhx60hgGtDjiEDqLqBURrrDE9Wjuovued7Hk08pZ9uOydS_6zIFV3TBRwHP2EeSGnubZamDO8u8BQMlHBwc0lHX05OQ7u3NGdO7pzR_fYcX3x7rp66Y8Yn_w13AreX4GnNdNQ_BQSPTmpuZRCrM5eHK4h_iYsjkLCKWBMBUN1Maf_fuIfHtaPkw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71797288</pqid></control><display><type>article</type><title>Clinical and pathophysiological characteristics of acute-onset functional dyspepsia</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><source>Alma/SFX Local Collection</source><creator>Tack, Jan ; Demedts, Ingrid ; Dehondt, Geert ; Caenepeel, Philip ; Fischler, Benjamin ; Zandecki, Michele ; Janssens, Jozef</creator><creatorcontrib>Tack, Jan ; Demedts, Ingrid ; Dehondt, Geert ; Caenepeel, Philip ; Fischler, Benjamin ; Zandecki, Michele ; Janssens, Jozef</creatorcontrib><description>Background &amp; Aims: Functional bowel disorders may follow acute intestinal infection. In animals, postinflammatory dysmotility is associated with nitrergic dysfunction. The aim of this study was to identify and characterize patients with presumed postinfectious dyspepsia (PD) compared with unspecified-onset dyspepsia (UD). Methods: A total of 400 consecutive dyspeptic patients filled out a questionnaire to assess whether their symptoms were of postinfectious origin. They underwent testing for Helicobacter pylori infection as well as gastric emptying and gastric barostat studies. Pharmacological studies of nitrergic gastric function were performed in controls, in patients with presumed PD, and in patients with UD using sumatriptan, an activator of nitrergic neurons, and amylnitrite, a nitric oxide donor. Results: Presumed PD was present in 17% of the patients and associated with more prevalent early satiety, weight loss, nausea, and vomiting compared with UD. Both groups did not differ in H. pylori infection, gastric emptying, or gastric sensitivity. Impaired accommodation was significantly more prevalent in patients with presumed PD (67% vs. 30%; P &lt; 0.05). Sumatriptan relaxed the stomach in controls and patients with UD but not in patients with presumed PD, whereas amyl nitrite relaxed the stomach in all subjects. Conclusions: A subset of dyspeptic patients has a history suggestive of postinfectious dyspepsia. These patients have a high prevalence of impaired accommodation attributable to a dysfunction at the level of gastric nitrergic neurons. GASTROENTEROLOGY 2002;122:1738-1747</description><identifier>ISSN: 0016-5085</identifier><identifier>EISSN: 1528-0012</identifier><identifier>DOI: 10.1053/gast.2002.33663</identifier><identifier>PMID: 12055579</identifier><identifier>CODEN: GASTAB</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Adolescent ; Adult ; Age of Onset ; Aged ; Aged, 80 and over ; Amyl Nitrite - pharmacology ; Biological and medical sciences ; Digestive system ; Dyspepsia - epidemiology ; Dyspepsia - microbiology ; Dyspepsia - physiopathology ; Enzyme Inhibitors - pharmacology ; Female ; Gastrointestinal Motility - drug effects ; Helicobacter Infections - complications ; Helicobacter pylori ; Humans ; Investigative techniques, diagnostic techniques (general aspects) ; Male ; Medical sciences ; Middle Aged ; omega-N-Methylarginine - pharmacology ; Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques ; Reference Values ; Sumatriptan - pharmacology ; Surveys and Questionnaires</subject><ispartof>Gastroenterology (New York, N.Y. 1943), 2002-06, Vol.122 (7), p.1738-1747</ispartof><rights>2002 American Gastroenterological Association</rights><rights>2002 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c354t-d72a88836736b4214036710b0770fe97cefc60d5b20d98988be99f5bb163b1d83</citedby><cites>FETCH-LOGICAL-c354t-d72a88836736b4214036710b0770fe97cefc60d5b20d98988be99f5bb163b1d83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1053/gast.2002.33663$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=13713322$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12055579$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tack, Jan</creatorcontrib><creatorcontrib>Demedts, Ingrid</creatorcontrib><creatorcontrib>Dehondt, Geert</creatorcontrib><creatorcontrib>Caenepeel, Philip</creatorcontrib><creatorcontrib>Fischler, Benjamin</creatorcontrib><creatorcontrib>Zandecki, Michele</creatorcontrib><creatorcontrib>Janssens, Jozef</creatorcontrib><title>Clinical and pathophysiological characteristics of acute-onset functional dyspepsia</title><title>Gastroenterology (New York, N.Y. 1943)</title><addtitle>Gastroenterology</addtitle><description>Background &amp; Aims: Functional bowel disorders may follow acute intestinal infection. In animals, postinflammatory dysmotility is associated with nitrergic dysfunction. The aim of this study was to identify and characterize patients with presumed postinfectious dyspepsia (PD) compared with unspecified-onset dyspepsia (UD). Methods: A total of 400 consecutive dyspeptic patients filled out a questionnaire to assess whether their symptoms were of postinfectious origin. They underwent testing for Helicobacter pylori infection as well as gastric emptying and gastric barostat studies. Pharmacological studies of nitrergic gastric function were performed in controls, in patients with presumed PD, and in patients with UD using sumatriptan, an activator of nitrergic neurons, and amylnitrite, a nitric oxide donor. Results: Presumed PD was present in 17% of the patients and associated with more prevalent early satiety, weight loss, nausea, and vomiting compared with UD. Both groups did not differ in H. pylori infection, gastric emptying, or gastric sensitivity. Impaired accommodation was significantly more prevalent in patients with presumed PD (67% vs. 30%; P &lt; 0.05). Sumatriptan relaxed the stomach in controls and patients with UD but not in patients with presumed PD, whereas amyl nitrite relaxed the stomach in all subjects. Conclusions: A subset of dyspeptic patients has a history suggestive of postinfectious dyspepsia. These patients have a high prevalence of impaired accommodation attributable to a dysfunction at the level of gastric nitrergic neurons. GASTROENTEROLOGY 2002;122:1738-1747</description><subject>Adolescent</subject><subject>Adult</subject><subject>Age of Onset</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Amyl Nitrite - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Digestive system</subject><subject>Dyspepsia - epidemiology</subject><subject>Dyspepsia - microbiology</subject><subject>Dyspepsia - physiopathology</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Female</subject><subject>Gastrointestinal Motility - drug effects</subject><subject>Helicobacter Infections - complications</subject><subject>Helicobacter pylori</subject><subject>Humans</subject><subject>Investigative techniques, diagnostic techniques (general aspects)</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>omega-N-Methylarginine - pharmacology</subject><subject>Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques</subject><subject>Reference Values</subject><subject>Sumatriptan - pharmacology</subject><subject>Surveys and Questionnaires</subject><issn>0016-5085</issn><issn>1528-0012</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp10M-P1CAUwHFiNO64evZmetFbZx8wFDiaib-STTyoZ0LhdQfTKZVHTea_t7MzyZ48PUI-vJAvY285bDkoeffgqW4FgNhK2XXyGdtwJUwLwMVztllH1yow6oa9IvoNAFYa_pLdcAFKKW037Md-TFMKfmz8FJvZ10OeDydKecwPj9fh4IsPFUuimgI1eWh8WCq2eSKszbBMoaY8rTKeaMaZkn_NXgx-JHxznbfs1-dPP_df2_vvX77tP963QapdbaMW3hgjOy27fif4DtYjhx60hgGtDjiEDqLqBURrrDE9Wjuovued7Hk08pZ9uOydS_6zIFV3TBRwHP2EeSGnubZamDO8u8BQMlHBwc0lHX05OQ7u3NGdO7pzR_fYcX3x7rp66Y8Yn_w13AreX4GnNdNQ_BQSPTmpuZRCrM5eHK4h_iYsjkLCKWBMBUN1Maf_fuIfHtaPkw</recordid><startdate>200206</startdate><enddate>200206</enddate><creator>Tack, Jan</creator><creator>Demedts, Ingrid</creator><creator>Dehondt, Geert</creator><creator>Caenepeel, Philip</creator><creator>Fischler, Benjamin</creator><creator>Zandecki, Michele</creator><creator>Janssens, Jozef</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200206</creationdate><title>Clinical and pathophysiological characteristics of acute-onset functional dyspepsia</title><author>Tack, Jan ; Demedts, Ingrid ; Dehondt, Geert ; Caenepeel, Philip ; Fischler, Benjamin ; Zandecki, Michele ; Janssens, Jozef</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c354t-d72a88836736b4214036710b0770fe97cefc60d5b20d98988be99f5bb163b1d83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Age of Onset</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Amyl Nitrite - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Digestive system</topic><topic>Dyspepsia - epidemiology</topic><topic>Dyspepsia - microbiology</topic><topic>Dyspepsia - physiopathology</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Female</topic><topic>Gastrointestinal Motility - drug effects</topic><topic>Helicobacter Infections - complications</topic><topic>Helicobacter pylori</topic><topic>Humans</topic><topic>Investigative techniques, diagnostic techniques (general aspects)</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>omega-N-Methylarginine - pharmacology</topic><topic>Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques</topic><topic>Reference Values</topic><topic>Sumatriptan - pharmacology</topic><topic>Surveys and Questionnaires</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tack, Jan</creatorcontrib><creatorcontrib>Demedts, Ingrid</creatorcontrib><creatorcontrib>Dehondt, Geert</creatorcontrib><creatorcontrib>Caenepeel, Philip</creatorcontrib><creatorcontrib>Fischler, Benjamin</creatorcontrib><creatorcontrib>Zandecki, Michele</creatorcontrib><creatorcontrib>Janssens, Jozef</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Gastroenterology (New York, N.Y. 1943)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tack, Jan</au><au>Demedts, Ingrid</au><au>Dehondt, Geert</au><au>Caenepeel, Philip</au><au>Fischler, Benjamin</au><au>Zandecki, Michele</au><au>Janssens, Jozef</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical and pathophysiological characteristics of acute-onset functional dyspepsia</atitle><jtitle>Gastroenterology (New York, N.Y. 1943)</jtitle><addtitle>Gastroenterology</addtitle><date>2002-06</date><risdate>2002</risdate><volume>122</volume><issue>7</issue><spage>1738</spage><epage>1747</epage><pages>1738-1747</pages><issn>0016-5085</issn><eissn>1528-0012</eissn><coden>GASTAB</coden><abstract>Background &amp; Aims: Functional bowel disorders may follow acute intestinal infection. In animals, postinflammatory dysmotility is associated with nitrergic dysfunction. The aim of this study was to identify and characterize patients with presumed postinfectious dyspepsia (PD) compared with unspecified-onset dyspepsia (UD). Methods: A total of 400 consecutive dyspeptic patients filled out a questionnaire to assess whether their symptoms were of postinfectious origin. They underwent testing for Helicobacter pylori infection as well as gastric emptying and gastric barostat studies. Pharmacological studies of nitrergic gastric function were performed in controls, in patients with presumed PD, and in patients with UD using sumatriptan, an activator of nitrergic neurons, and amylnitrite, a nitric oxide donor. Results: Presumed PD was present in 17% of the patients and associated with more prevalent early satiety, weight loss, nausea, and vomiting compared with UD. Both groups did not differ in H. pylori infection, gastric emptying, or gastric sensitivity. Impaired accommodation was significantly more prevalent in patients with presumed PD (67% vs. 30%; P &lt; 0.05). Sumatriptan relaxed the stomach in controls and patients with UD but not in patients with presumed PD, whereas amyl nitrite relaxed the stomach in all subjects. Conclusions: A subset of dyspeptic patients has a history suggestive of postinfectious dyspepsia. These patients have a high prevalence of impaired accommodation attributable to a dysfunction at the level of gastric nitrergic neurons. GASTROENTEROLOGY 2002;122:1738-1747</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>12055579</pmid><doi>10.1053/gast.2002.33663</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0016-5085
ispartof Gastroenterology (New York, N.Y. 1943), 2002-06, Vol.122 (7), p.1738-1747
issn 0016-5085
1528-0012
language eng
recordid cdi_proquest_miscellaneous_71797288
source MEDLINE; ScienceDirect Journals (5 years ago - present); Alma/SFX Local Collection
subjects Adolescent
Adult
Age of Onset
Aged
Aged, 80 and over
Amyl Nitrite - pharmacology
Biological and medical sciences
Digestive system
Dyspepsia - epidemiology
Dyspepsia - microbiology
Dyspepsia - physiopathology
Enzyme Inhibitors - pharmacology
Female
Gastrointestinal Motility - drug effects
Helicobacter Infections - complications
Helicobacter pylori
Humans
Investigative techniques, diagnostic techniques (general aspects)
Male
Medical sciences
Middle Aged
omega-N-Methylarginine - pharmacology
Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques
Reference Values
Sumatriptan - pharmacology
Surveys and Questionnaires
title Clinical and pathophysiological characteristics of acute-onset functional dyspepsia
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T02%3A38%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20and%20pathophysiological%20characteristics%20of%20acute-onset%20functional%20dyspepsia&rft.jtitle=Gastroenterology%20(New%20York,%20N.Y.%201943)&rft.au=Tack,%20Jan&rft.date=2002-06&rft.volume=122&rft.issue=7&rft.spage=1738&rft.epage=1747&rft.pages=1738-1747&rft.issn=0016-5085&rft.eissn=1528-0012&rft.coden=GASTAB&rft_id=info:doi/10.1053/gast.2002.33663&rft_dat=%3Cproquest_cross%3E71797288%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71797288&rft_id=info:pmid/12055579&rft_els_id=S0016508502000069&rfr_iscdi=true